PRO 95780, rhuMAb-DR 5, Anti-Human DR5 Recombinant Antibody
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma[1][2][3].
Molecular Weight:
(143.06 kDa)
Purity:
99.00
CAS Number:
[912628-39-8]
Target:
Apoptosis
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted